Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:50 PM
Ignite Modification Date:
2025-12-24 @ 11:50 PM
NCT ID:
NCT01288651
Eligibility Criteria:
Inclusion Criteria:
* Stable idiopathic pulmonary arterial hypertension (stable disease for at least 3 months)
* iron deficiency (serum iron below 10 μmol/l, decreased transferrin saturation (\< 15% in females and \< 20% in males) and serum ferritin \< 100 μg/l) irrespective of the coexistence of anaemia
Exclusion Criteria:
* Current iron therapy (oral or iv)
* Current other study medication for PAH
* History of anaemia or current treatment for anaemia
* Liver function impairment
* Chronic disease other than PAH (rheumatism, asthma, chronic infection)
* Acute infection
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01288651
Study Brief:
Protocol Section:
NCT01288651